HBM Holdings (HBM Holdings) Change In Inventory : $1.04 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is HBM Holdings Change In Inventory?

HBM Holdings's change in inventory for the quarter that ended in Dec. 2023 was $1.00 Mil. It means HBM Holdings's inventory declined by $1.00 Mil from Jun. 2023 to Dec. 2023 .

HBM Holdings's change in inventory for the fiscal year that ended in Dec. 2023 was $1.04 Mil. It means HBM Holdings's inventory declined by $1.04 Mil from Dec. 2022 to Dec. 2023 .

HBM Holdings's Total Inventories for the quarter that ended in Dec. 2023 was $0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. HBM Holdings's Days Inventory for the quarter that ended in Dec. 2023 was 45.38.

Inventory Turnover measures how fast the company turns over its inventory within a year. HBM Holdings's Inventory Turnover for the quarter that ended in Dec. 2023 was 4.02.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. HBM Holdings's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.01.

HBM Holdings Change In Inventory Historical Data

The historical data trend for HBM Holdings's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HBM Holdings Change In Inventory Chart

HBM Holdings Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-1.04

1.04

HBM Holdings Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Inventory	Get a 7-Day Free Trial						-	-	-	0.04	1.00

HBM Holdings Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $1.04 Mil.

HBM Holdings (OTCPK:HBMHF) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

HBM Holdings's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0.5	/	2.011	*	365 / 2
	=	45.38

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

HBM Holdings's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	2.011	/	0.5
	=	4.02

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

HBM Holdings's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.5	/	48.506
	=	0.01

HBM Holdings Change In Inventory Related Terms

Thank you for viewing the detailed overview of HBM Holdings's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

HBM Holdings (HBM Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HBM Holdings Ltd (OTCPK:HBMHF) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

02142:Hong Kong

Address

420 Fenglin Road, 12th Floor, Tower A, Fenglin International Plaza Phase II, Xuhui District, Shanghai, CHN, 200032

Website

https://www.harbourbiomed.com

HBM Holdings Ltd is a clinical-stage biopharmaceutical company engaged in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas. Its products under development are Batoclimab, for the treatment of a wide spectrum of autoimmune diseases; Tanfanercept, for the treatment of moderate-to-severe dry eye disease (DED); HBM4003; HBM9378, to prevent and treat COVID-19, the pandemic respiratory disease caused by the SARS-CoV-2 virus; HBM7008; and others. Its geographical segments are Mainland China, United States, Europe, and others. Majority of revenue is generated from Europe.

HBM Holdings (HBM Holdings) Headlines

From GuruFocus

Harbour BioMed Announces Positive Profit Alert

By PRNewswire • 01-19-2024